メチオニン制限はがん特異的な脆弱性であるが、システイン制限はそうではない
Yuta Miyashi1,2,3, Kohei Mizuta1,2,3, Yohei Asano1,2
1AntiCancer, Inc., San Diego, CA, U.S.A.
Anticancer research
|December 30, 2025
まとめ
メチオニン制限(MR)は、正常細胞とがん細胞の両方に害を与えるシステイン制限(CR)とは異なり、がん細胞を選択的に標的とする。CRはがん特異的な脆弱性ではなく、フェロプトーシスを誘導するための治療の可能性を制限する。
科学分野:
- 腫瘍学
- 細胞生物学
- 生化学
背景:
- システイン制限(CR)によるフェロプトーシス誘導は、がんにおける最近の研究焦点である。
- メチオニン制限(MR)は確立されたがん特異的な脆弱性である。
主な方法:
- ヒトがん細胞株(HCT116、143B、HT1080)と正常ヒト線維芽細胞(Hs27)の共培養。
- メチオニン、システイン、またはその両方を枯渇させた培地での細胞培養。
- 細胞生存率と増殖の顕微鏡的視覚化。
結論:
- メチオニン制限(MR)はがん特異的な脆弱性である。
- システイン制限(CR)は正常細胞とがん細胞の両方に毒性があり、がん特異性を欠いている。
- CRは、その非特異的な毒性のために、フェロプトーシスを誘導するための効果的ながん治療法である可能性は低い。
さらに関連する動画
関連する概念動画
Mismatch Repair
6.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.2K
Mismatch Repair
43.4K
Overview
43.4K
Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Translation
154.9K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
154.9K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


